Fig. 3
Schematic representation of cardiotoxicity screening before, during, and after cancer therapy. Specific screening criteria based on the types the therapies are proposed. CMR, cardiac MRI; and HER, human epidermal growth factor receptor
Fig. 3 | Signal Transduction and Targeted Therapy
